Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
about
How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugsThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaHigh adherence to antimalarials and antibiotics under integrated community case management of illness in children less than five years in eastern UgandaAdherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidenceThe Impact of a Community Awareness Strategy on Caregiver Treatment Seeking Behaviour and Use of Artemether-Lumefantrine for Febrile Children in Rural KenyaEffective coverage and systems effectiveness for malaria case management in sub-Saharan African countriesExperience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.Public policy, health system, and community actions against illness as platforms for response to NCDs in Tanzania: a narrative review.Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Adherence to artemether-lumefantrine drug combination: a rural community experience six years after change of malaria treatment policy in Tanzania.Mobile phone text messaging: tool for malaria control in Africa.Artemether-lumefantrine: an option for malaria.Cluster randomized trial of text message reminders to retail staff in tanzanian drug shops dispensing artemether-lumefantrine: effect on dispenser knowledge and patient adherencePrimacy of effective communication and its influence on adherence to artemether-lumefantrine treatment for children under five years of age: a qualitative study.The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.Are Tanzanian patients attending public facilities or private retailers more likely to adhere to artemisinin-based combination therapy?Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, EthiopiaSubstandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight rangesDo patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in UgandaProvider compliance to artemisinin-based combination therapy at primary health care facilities in the middle belt of Ghana.Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya.High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the CongoThe global pipeline of new medicines for the control and elimination of malariaEffects of malaria volunteer training on coverage and timeliness of diagnosis: a cluster randomized controlled trial in Myanmar.Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study.Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.Provider and user acceptability of intermittent screening and treatment for the control of malaria in pregnancy in Malawi.Intervention to promote patients' adherence to antimalarial medication: a systematic review.Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trialNovartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Artemether and lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-AnalysisCoartem(®): a decade of patient-centric malaria management.Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial.Patients' Knowledge of Artemisinin-Based Combination Therapy Treatment and Its Impact on Patient Adherence
P2860
Q26823483-4A52A7F8-99C1-4568-B733-735CFA2DCAC7Q28478579-3C3062AD-5E72-4496-B4DD-CD35501ED722Q28489120-8A6018DE-5CD8-454D-B025-603BE5FA9FB3Q28538749-1CFD1906-892B-471E-A88D-135EAC6DF3E6Q28546118-FCBB71F5-9746-4456-A2C5-00FED3D3F369Q28547444-3798896D-F4AA-461F-978D-AFDCC0F574DEQ30396779-0DB74E96-40CA-4509-BBE9-A49DACE0C0FCQ33641489-AFD2843F-6F8C-447E-B0CF-55769F7D6C49Q33678483-B0CD47D1-A2F4-444F-B5F7-A55A21EE6675Q33928184-F8221509-DAC8-4572-8965-A28EDB8C7E40Q34169722-3A913366-065C-41A5-BE87-BE2BCF5E9676Q34267667-B4435AFB-7D72-482C-9771-0C9CF5B5B3C4Q34281687-683746B5-8191-479D-9CA8-74D7B58B1611Q34298037-96C853B2-1EEB-47E7-9A2D-E0A6AB153FCAQ34558411-359B60E4-DAA7-4614-B1D3-3A97C4948F0CQ35122087-444A4715-D95E-4BA4-A804-9741A827A67DQ35299140-AE10E5FE-DCA9-4001-96DB-DDB291C77A50Q35642797-1C0432D8-78E4-4ED8-8F18-2FB71081A26EQ35681822-7BAAE75C-826F-491C-A09B-E48BD8366494Q35834482-CF29D808-6DAD-4D2A-B30B-78500723EB02Q35928018-2F8E9267-0842-4E6B-9099-571220E74C05Q36082548-B68AA34C-BE6E-4E97-BE73-ED9A021CA64CQ36173400-FB9A6992-D73E-4531-90A8-11C2C13FBC8EQ36190074-2D546DAF-52B7-4994-BFAA-E122CD1CC24FQ36320249-542CA40C-282E-4143-B558-E6E1156829B2Q36368129-1717F9A1-711E-46E4-B266-AC914EAF7FC5Q36667896-976EC85F-62C2-4C7D-A4D0-CDA58EFA1938Q37038270-03692C27-142F-4870-A29B-280B1F0F8DF7Q37449795-D8AE069F-F901-4FE3-9F2A-60D1C5D026B7Q37456044-D58C6236-31DD-48BB-8BAC-63ECBC4EC4C7Q37607723-9F3CA496-514B-4C6D-8392-5A0ACC24D95DQ37857327-551B2B87-759B-4AB8-B3EF-373D4948C62FQ38082548-1CE0DAB6-AEF2-40E5-8A64-942DC9C7762FQ38544762-79111744-B7BD-470B-8145-9CEDB10A7CC4Q39042892-CF37ACEE-6061-493B-87B1-A2C074929950Q43927844-994E277F-7DAF-420C-A231-47F75866216DQ56361504-93CEE2E7-217F-484A-B570-98105A20E6C0
P2860
Adherence to and acceptability of artemether-lumefantrine as first-line anti-malarial treatment: evidence from a rural community in Tanzania.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adherence to and acceptability ...... a rural community in Tanzania.
@ast
Adherence to and acceptability ...... a rural community in Tanzania.
@en
type
label
Adherence to and acceptability ...... a rural community in Tanzania.
@ast
Adherence to and acceptability ...... a rural community in Tanzania.
@en
prefLabel
Adherence to and acceptability ...... a rural community in Tanzania.
@ast
Adherence to and acceptability ...... a rural community in Tanzania.
@en
P2093
P2860
P356
P1433
P1476
Adherence to and acceptability ...... a rural community in Tanzania.
@en
P2093
Abdunoor M Kabanywanyi
Nathan Mulure
Prudensiana Kasim
Raymond Schlienger
Said King'eng'ena
P2860
P2888
P356
10.1186/1475-2875-9-48
P577
2010-02-11T00:00:00Z
P5875
P6179
1012468507